There was general consensus among panel members that no single approach to postmarketing safety studies would likely be sufficient to evaluate new or existing products, and that complementary approaches are needed.
A complete set of the panelists’ slide presentations from the public meeting as well as webcasts of the 2-day proceedings in their entirety are available for viewing here.
Dr. Chambers is a professor of pediatrics and director of clinical research at Rady Children’s Hospital, and associate director of the Clinical and Translational Research Institute at the University of California, San Diego. She is director of MotherToBaby California, a past president of the Organization of Teratology Information Specialists, and past president of the Teratology Society. She said that she had no relevant financial disclosures. To comment, e-mail her at obnews@frontlinemedcom.com.